Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1998-04-29
2000-10-17
Witz, Jean C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514188, 514561, A61K 3578
Patent
active
061327247
ABSTRACT:
Enhancement of attentional processing is attained by administration of an endorphinase inhibitor or enkephalinase inhibitor and optionally, a dopamine precursor, or a serotonin precursor, a GABA precursor, or an endorphin or enkephalinase releaser, or certain herbal compounds including Rhodiola rosea extract (Pharmaline) and/or Huperzine. These components promote restoration of normal neurotransmitter function and the components combined enhance the release of dopamine at the nucleus accumbens and are non-addictive. Use of the dopamine precursors L-phenylalanine, or L-Tyrosine, the enkephalinase inhibitor D-phenylalanine, and/or the serotonin precursor -hydroxytryptophan and a natural acetylcholenesterase inhibitor and chromium salts (i.e. picolinate, nicotinate, etc.) is especially preferred, but not limited to assist in relieving symptoms associated with brain phenylalanine deficiency.
REFERENCES:
patent: 4650789 (1987-03-01), Pollack
patent: 4761429 (1988-08-01), Blum et al.
patent: 4897380 (1990-01-01), Pollack et al.
patent: 5013752 (1991-05-01), Dobbins
patent: 5019594 (1991-05-01), Wurtman et al.
patent: 5164384 (1992-11-01), Paul
patent: 5189064 (1993-02-01), Blum et al.
patent: 5210016 (1993-05-01), Blum et al.
patent: 5500343 (1996-03-01), Blum et al.
patent: 5543405 (1996-08-01), Keown et al.
patent: 5550021 (1996-08-01), Blum et al.
Abraham and Dufy, "Computed EEG abnormalities in panic disorder with and without premorbid drug abuse," Biol. Psychiatry, 29:687-690, 1991.
Accili et al., "A new look at D.sub.3 receptors," Mol. Psychiatry, 1:93-94, 1996.
Adams et al., "Neuropsychologicla deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients," Alcohol Clin. Exp. Res., 17:205-210, 1993.
Allen and Gorski, "Sex differences in the bed nucleus of the stria terminalis of the human brain," J. Comp. Neurol., 302:697-706, 1990.
Altura, B.M and Gebrewold, A. "Pyrrolidine Dithiocarbamate Attenuates Alcohol-Induced Leukocyte-Endothelial Cell Interaction and Cerebral Vascular Damage in Rats: Possible Role of Activation of Transcription Factor NF-.kappa.B in Alcohol Brain Pathology," Alcohol 16:25-28, 1998.
Amit and Brown, "Actions of drugs of abuse on brain reward systems: A reconsideration with specific attention to alcohol," Pharmacology Biochemistry and Behavior, 17:233-238, 1982.
Aoki, Go, Venkatesan, Kurose, "Perikaryal and synaptic localization of alpha-2A-adrenergic receptor-like immunoractivity," Brain Res., 650:181-204, 1994.
Arcot, Wang, Weber, Deininger, Batzer, "Alu repeats: a source for the genesis of primate microsatellites," Genomics, 29:136-144, 1995.
Arndt-Jovin, Udvardy, Garner, Ritter, Jovin, "Z-DNA binding and inhibition by GTP of Drosophilia topoisomerase II," Biochemistry, 32:4862-4872, 1993.
Arnsten, Steere, Hunt, "The contribution of a.sub.2 -noradrenergic mechanism to prefrontal cortical cognitive function. Potential significance for Attention-Deficit Hyperactivity Disorder," Arch. Gen. Psychiatry, 53:448-455, 1996.
Asghari et al., "Modulation of intercellular cyclic AMP levels by different human dopamine D.sub.4 receptor variants" J. Neurochem, 65:1157-1165, 1995.
Ashani,Grunwald, Kronman et al., Roles of tyrosine 337 in the binding of Huperzine A to the active site of human acetylcholinesterase, Mol. Pharmacol., 45:555-560, 1994.
Ashani, Peggins, Doctor, "Mechanism of inhibition of cholinesterase by Huperzine A," Biochem. Biophys. Res. Commun., 184:719-726, 1992.
Aston-Jones et al., "Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggest a role in vigilance" Progress in Brain Res., 88:501-520, 1991.
August and Garfinkel, "Behavioral and Cognitive Subtypes of AD-HD," J. Am. Acad. Child Adoles. Psychiatry, 28(5):739-748, 1989.
August et al., "Familial subtypes of childhood hyperactivity" J. Nerv. Ment. Dis., 171:362-368, 1972.
Bain, et al., "Naloxone attenuation of the effect of cocaine on rewarding brain stimulation," Life Sciences, 40:1119-1125, 1986.
Balfour and Fagerstrom, "Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders," Pharmac. Ther., 72:51-81, 1996.
Balldin et al., Further neuroendocrine evidence for reduced D.sub.2 dopamine receptor function in alcoholism, Drug Alcoh. Dep., 32:159-162, 1993.
Banerjee and Grunberger, "Enhanced expression of the bacterial chloramphenicol acetyltransferase gene in mouse cells cotransfected with synthetic polynucleotides able to form Z-DNA," Proc. Natl. Acad. Sci. USA, 83:4988-4992, 1986.
Banerjee, Carethers, Grunberger, "Inhibition of the herpes simplex virus thymidine kinase gene transfection in Ltk-cells by potential Z-DNA forming polymers," Nucl. Acids Res., 13:5111-5126, 1985.
Beckmann, et al., "DL-Phenylalanine in Depressed Patients: An Open Study," J. Neuronal Trans., 41:123-134, 1977.
Begleiter and Porjesz, "Potential biological markers in individuals at high risk for developing alcoholism", Alcohol Clin.. Exp. Res., 12:488-493, 1988.
Begleiter and Porjesz, "Neuroelectric processes in individuals at risk for alcoholism," Alcohol and Alcoholism, 25:251-256, 1990.
Bella et al., "Effect of carboxypeptidase inhibition on the in vivo and in vitro pharmacological properties of morphine and enkephalins," Neuropharmacology, 18:719-721, 1979.
Benjamin, Li, Patterson, Greenberg, Murphy, Hamer, "Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking," Nature Genet., 12:81-84, 1996.
Bennett, Lucassen, Grough, Pewell, Undlien, Pritchard, Merriman, Kawaguchi, Dronsfeld, Pociot, Nerup, Bouzekri, Cambon-Thomsen, Ronning, Barnett, Bain, Todd, "Susceptibility to human type 1 diabetes at IDDMC2 is determined by tandem repeat variation at the insulin gene minisatellite locus," Nature Genet., 9:284-292, 1955.
Benuck, et al., "Rat Brain and Kidney Metalloendopeptidase: Enkephalin Heptapeptide Conversion to Form a Cardioactive Neuropeptide, Phe-Met-Arg-Phe-Amide," Biophys. Res. Commun., 107:1123-1129, 1982.
Berman et al., "Reduced viso-spatial performance in children with the D.sub.2 dopamine receptor A.sub.1, allele" Behav. Genet., 25:45-58, 1995.
Beyer and Feder, "Sex steroids and afferent input: their roles in brain sexual differentiation," Annu. Rev. Physiol., 49:349-364, 1987.
Biederman et al., "Evidence of familial association between attention disorder and major affective disorders" Arch. Gen. Psychiatry, 48:526-533, 1990a.
Biederman, Faraone, Keenan, Knee, Tsuang, "Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder," J. Amer. Acad. Child Adolescent Psychiat., 29:526-533, 1990b.
Biederman, Newcom, Sprich, "Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders," Am. J. Psychiatry, 148:564-577, 1991.
Biederman, Faraone, Spencer, Wilens, Norman, Lapey, Mick, Lehman, Doyle, "Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder," Am. J. Psychiatry, 150:1792-1798, 1993.
Biggio et al., "Stimulation of dopamine synthesis in caudate nucleus by intrastriatial enkephalins and antagonism by naloxone," Science, 200:552-54, 1978.
Black, Chenz, Craig, Powell, "Dinucleotide repeat polymorphism at the MAOA locus," Nucleic Acids Res., 19:689, 1991.
Bloom et al., "Neurons containing .beta.-endorphin in rat brain exist separately from those containing enkephalin: Immunocytochemical studies," Proc. Natl. Acad. Sci., USA, 75: 1591-1595, 1978.
Blum et al., "Methionine enkephalinase as a possible neuromodulator of regional cerebral blood flow," Experimentia, 41:932-933, 1985.
Blum et al., "The D.sub.2 dopamine receptor gene as a determinant of reward deficiency syndrome," J. Royal Soc. Of Med., 89:396-400, 1996b.
Blum, "A commentary on neurotransmitter restoration as a common mode of treatment for alcohol, cocaine and opiate abuse," Integrative Psychiatry, 6:199-204, 1989a.
Blum, Allison, Trachtenberg, Williams, Loeblich, "Reduction of both drug hunger and withdrawal against advice r
City of Hope National Medical Center
Hodgins Daniel S.
The University of Texas System AMD Board of Regents
Witz Jean C.
LandOfFree
Allelic polygene diagnosis of reward deficiency syndrome and tre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allelic polygene diagnosis of reward deficiency syndrome and tre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allelic polygene diagnosis of reward deficiency syndrome and tre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-465782